Molecular Templates to Present at the Upcoming Investor Conferences
AUSTIN, Texas, March 01, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, will participate in several upcoming investor conferences.
| Details can be found below: | |
| Cowen’s 42nd Annual Health Care Conference (March 7-9, 2022) | |
| Format: | Corporate Presentation |
| Date: | Tuesday, March 8th |
| Time: | 10:30 AM – 11:00 AM ET |
| Oppenheimer’s 32nd Annual Healthcare Conference (March 15-16, 2022) | |
| Format: | Corporate Presentation |
| Date: | Wednesday, March 16 |
| Time: | 2:00 PM – 2:30 PM ET |
| Barclays Global Healthcare Conference 2022 (March 15-17, 2022) | |
| Format: | Corporate Presentation |
| Date: | Tuesday, March 15 |
| Time: | 4:20 PM - 4:45 PM ET |
Webcast links for the presentations will be posted on the “News and Media” section of the Molecular Templates corporate website, under Events.
About Molecular Templates Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.
Investor Contact:Joyce AllaireLifeSci Advisors, LLC[email protected]
Source: Molecular Templates, Inc.
Source: Molecular Templates, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SOUEAST C-DM Hybrid System: Adapting to Urban and Intercity Travel Needs
- Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
- Best’s Market Segment Report: Asia-Pacific Reinsurers Show Resilience Amid Evolving Market Landscapes
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Barclays, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share